Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clot Retraction and Fibrinolysis

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.

Formation of the Platelet Plug

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ultrasonic Deep-Plane Neck Lift.

Facial plastic surgery : FPS·2023

Same author

Evaluating, Purchasing, and Incorporating High-Tech Equipment into a Facial Plastic Surgery Practice.

Facial plastic surgery clinics of North America·2020

Same author

Ultrasound-Assisted Rhytidectomy Including Sub-SMAS and Subplatysmal Dissection.

Facial plastic surgery : FPS·2020

Same author

Laser-Assisted Facelifting and Energy-Based Rejuvenation Techniques During Rhytidectomy.

Facial plastic surgery clinics of North America·2020

Same author

Renuvion RF-Helium Plasma for Subdermal Skin Tightening, Facial Contouring and Skin Rejuvenation of the Face and Neck.

Facial plastic surgery & aesthetic medicine·2020

Same author

Pulsed and Fractionated Techniques for Helium Plasma Energy Skin Resurfacing.

Facial plastic surgery clinics of North America·2019

Search research articles

Related Experiment Video

Updated: Jan 3, 2026

Characterization of Leukocyte-platelet Rich Fibrin, A Novel Biomaterial

Characterization of Leukocyte-platelet Rich Fibrin, A Novel Biomaterial

Published on: September 29, 2015

Easy Platelet-Rich Fibrin (Injectable/Topical) for Post-resurfacing and Microneedle Therapy.

Richard D Gentile¹

¹Facial Plastic Surgery, Gentile Facial Plastic Surgery and Aesthetic Laser Center, 821 Kentwood Suite C, Youngstown, OH 44512, USA; Facial Plastic Surgery, Cleveland Clinic Akron General Hospital, Akron, OH, USA.

Facial Plastic Surgery Clinics of North America

|November 30, 2019

Summary

Producing platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) is complex and costly, hindering their use in facial plastic surgery. Lack of standardization complicates efficacy assessment and protocol comparison for these blood biologics.

Keywords:

Microneedle therapy PRF Platelet-rich plasma Platelets

More Related Videos

PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP

PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP

Published on: April 9, 2013

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

Related Experiment Videos

Last Updated: Jan 3, 2026

Characterization of Leukocyte-platelet Rich Fibrin, A Novel Biomaterial

Characterization of Leukocyte-platelet Rich Fibrin, A Novel Biomaterial

Published on: September 29, 2015

PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP

PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP

Published on: April 9, 2013

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

Area of Science:

Regenerative Medicine
Biologics
Facial Plastic Surgery

Background:

Platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) are blood-derived biologics with potential applications.
Current methods for obtaining PRP and PRF are often complicated and expensive.
The use of these biologics is influenced by numerous vendors and proprietary techniques.

Purpose of the Study:

To highlight the challenges associated with the procurement of PRP and PRF.
To discuss the controversial indications for PRP/PRF use.
To underscore the impact of procurement complexity on clinical adoption.

Main Methods:

Review of current literature on PRP and PRF procurement.
Analysis of vendor-specific techniques and proprietary systems.
Discussion of the implications of non-standardized methods.

Main Results:

PRP/PRF generation processes are complex, costly, and lack standardization.
The variety of techniques and vendors creates barriers for adoption.
Controversy surrounds the clinical indications for PRP/PRF.

Conclusions:

Complex and expensive PRP/PRF generation methods may deter facial plastic surgeons.
Lack of standardization impedes the assessment of clinical efficacy.
Standardization is crucial for comparing study protocols and establishing reliable clinical outcomes.